IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT
AssigneeBellerophon Therapeutics
InventorsParag SHAH, Peter FERNANDES
Life of this patent
Estimating the term…
Abstract
Described are methods for reducing pulmonary resistance, reducing pulmonary pressure, and increasing pulmonary arterial compliance by providing a inhaled nitric oxide.
Claims6
A method of reducing pulmonary pressure comprising delivering to a patient one or more doses of inhaled nitric oxide over a time period.
A method of reducing pulmonary resistance comprising delivering to a patient one or more doses of inhaled nitric oxide over a time period.
A method of increasing arterial compliance comprising delivering to a patient one or more doses of inhaled nitric oxide over a time period.
The method of any of the preceding claims wherein the time period is 5, 10, 15, 20, 25, 30, 60, or 90 minutes.
The method of any of the preceding claims wherein the dose of inhaled nitric oxide is a dose-escalating pulsed dose.
The method of any of the preceding claims wherein the dose of inhaled nitric oxide is one or more of a iNO30, iNO45, and iNO75 dose.
Dependencies are inferred from the claim text.